His main research concerns Internal medicine, Pathology, Neuroendocrine tumors, Gastroenterology and Cancer. His Internal medicine research incorporates themes from Endocrinology and Oncology. The study incorporates disciplines such as Rectum and Radionuclide therapy in addition to Pathology.
His research integrates issues of Radiation therapy, Surgery, Embolization, Transplantation and Chromogranin A in his study of Neuroendocrine tumors. His Gastroenterology research incorporates elements of Cecum, Gastrin and Adenocarcinoma. The various areas that he examines in his Cancer study include Stage, Epidemiology and Bioinformatics.
His primary areas of investigation include Internal medicine, Endocrinology, Pathology, Neuroendocrine tumors and Gastroenterology. His research investigates the connection between Internal medicine and topics such as Oncology that intersect with problems in Liquid biopsy. His Endocrinology research is multidisciplinary, incorporating perspectives in Receptor, Vasoactive intestinal peptide and Peptide YY.
He works in the field of Pathology, focusing on Carcinoid tumors in particular. His work deals with themes such as Cancer, Cancer research, Radionuclide therapy, Chromogranin A and Biomarker, which intersect with Neuroendocrine tumors. His work on Disease expands to the thematically related Gastroenterology.
The scientist’s investigation covers issues in Internal medicine, Neuroendocrine tumors, Oncology, Pathology and Biomarker. Irvin M. Modlin has researched Internal medicine in several fields, including Gastroenterology and Endocrinology. Irvin M. Modlin combines subjects such as Cancer, Cancer research, Radionuclide therapy, Somatostatin and Receiver operating characteristic with his study of Neuroendocrine tumors.
Lung, Gene expression and Tumor Status is closely connected to Progressive disease in his research, which is encompassed under the umbrella topic of Oncology. The Pathology study combines topics in areas such as Stomach, Transcriptome, Gene cluster, Gene signature and Adenocarcinoma. His study in Biomarker is interdisciplinary in nature, drawing from both Transcript analysis, Positron emission tomography, Disease management and Circulating tumor cell.
Irvin M. Modlin spends much of his time researching Internal medicine, Neuroendocrine tumors, Oncology, Biomarker and Chromogranin A. Irvin M. Modlin interconnects Endocrinology, Cancer research and Pathology in the investigation of issues within Internal medicine. His research integrates issues of Cancer, Transcriptome, Positron emission tomography, Nuclear medicine and Computational biology in his study of Neuroendocrine tumors.
His Oncology research is multidisciplinary, incorporating elements of Marker gene, Immunology, Radionuclide therapy, Liquid biopsy and Breast cancer. His studies in Biomarker integrate themes in fields like Transcript analysis, Disease and Receiver operating characteristic. His Chromogranin A research incorporates themes from Gastroenterology, Molecular biology, Grading and Blood test.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A 5‐decade analysis of 13,715 carcinoid tumors
Irvin M. Modlin M.D.;Kevin D. Lye;Mark Kidd.
Cancer (2003)
Gastroenteropancreatic neuroendocrine tumours.
Irvin M Modlin;Kjell Oberg;Daniel C Chung;Robert T Jensen.
Lancet Oncology (2008)
Current status of gastrointestinal carcinoids.
Irvin M. Modlin;Mark Kidd;Igor Latich;Michelle N. Zikusoka.
Gastroenterology (2005)
The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
Ben Lawrence;Bjorn I. Gustafsson;Anthony Chan;Bernhard Svejda.
Endocrinology and Metabolism Clinics of North America (2011)
The diagnosis and management of adult intussusception.
Dennis G. Begos;Dennis G. Begos;Andras Sandor;Andras Sandor;Irvin M. Modlin;Irvin M. Modlin.
American Journal of Surgery (1997)
Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference.
Dervenis C;Johnson Cd;Bassi C;Bradley E.
International Journal of Pancreatology (1999)
Neuroendocrine tumor epidemiology: contrasting Norway and North America.
Oyvind Hauso;Oyvind Hauso;Bjorn I. Gustafsson;Bjorn I. Gustafsson;Mark Kidd;Helge L. Waldum.
Cancer (2008)
Bronchopulmonary neuroendocrine tumors
Bjorn I. Gustafsson;Bjorn I. Gustafsson;Mark Kidd;Anthony Chan;Max V. Malfertheiner.
Cancer (2008)
Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion
A. Ferrara;J. D. Macarthur;H. K. Wright;I. M. Modlin.
American Journal of Surgery (1990)
Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours.
I. M. Modlin;M. Pavel;M. Kidd;B. I. Gustafsson.
Alimentary Pharmacology & Therapeutics (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Vanderbilt University
Memorial Sloan Kettering Cancer Center
Erasmus University Rotterdam
Uppsala University Hospital
Erasmus University Rotterdam
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
University of North Dakota
Yale University
Yale University
Otto-von-Guericke University Magdeburg
University of Maryland, College Park
University of Notre Dame
Polytechnic University of Turin
KU Leuven
Queen's University
University of Melbourne
Technical University of Munich
University of Manchester
Princeton University
École Polytechnique Fédérale de Lausanne
University of Geneva
University of Münster
The University of Texas Health Science Center at Houston
University College London
American University
Space Telescope Science Institute